UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The New England journal of medicine, ISSN 0028-4793, 08/2008, Volume 359, Issue 8, pp. 789 - 799
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Simvastatin - therapeutic use | Simvastatin - adverse effects | Humans | Middle Aged | Diabetes Mellitus - drug therapy | Genotype | Male | Risk | Genetic Markers | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacokinetics | Organic Anion Transporters - genetics | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Myocardial Infarction - drug therapy | Arterial Occlusive Diseases - drug therapy | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Female | Aged | Myocardial Infarction - prevention & control | Polymorphism, Single Nucleotide | Chromosomes, Human, Pair 12 | Muscular Diseases - chemically induced | Muscular Diseases - genetics | Solute Carrier Organic Anion Transporter Family Member 1b1 | Complications and side effects | Analysis | Muscle diseases | Genetic aspects | Dosage and administration | Single nucleotide polymorphisms | Risk factors | Statins | Drug therapy | Kinases | Drug dosages | Cholesterol | Index Medicus | Abridged Index Medicus | MEDICIN OCH HÄLSOVETENSKAP | Single Nucleotide | genetics | Arterial Occlusive Diseases | pharmacokinetics | Muscular Diseases | Hydroxymethylglutaryl-CoA Reductase Inhibitors | Chromosomes | MEDICAL AND HEALTH SCIENCES | Human | drug therapy | chemically induced | Simvastatin | prevention & control | Diabetes Mellitus | Myocardial Infarction | Pair 12 | Organic Anion Transporters | adverse effects | therapeutic use | Polymorphism
Journal Article
Physical review letters, ISSN 0031-9007, 05/2016, Volume 116, Issue 22, pp. 221101 - 221101
Physics, Multidisciplinary | Physical Sciences | Physics | Science & Technology | Phases | Wavelengths | Relativity | Waveforms | Gravitational fields | Black holes (astronomy) | Mathematical models | Gravitons | Physics - General Relativity and Quantum Cosmology | General Relativity and Quantum Cosmology
Journal Article
Physical review letters, ISSN 0031-9007, 2009, Volume 103, Issue 23, pp. 231801 - 231801
Physics, Multidisciplinary | Physical Sciences | Physics | Science & Technology | Physics - High Energy Physics - Experiment | High Energy Physics - Experiment | LUMINOSITY | ANTIPARTICLES | CENTER-OF-MASS SYSTEM | ELECTRONS | ENERGY RANGE | FERMIONS | MUONS | ANTIMATTER | BOSONS | ELECTRON-POSITRON INTERACTIONS | CROSS SECTIONS | LEPTONS | ANTILEPTONS | PHYSICAL PROPERTIES | OPTICAL PROPERTIES | MUONS MINUS | LEPTON-LEPTON INTERACTIONS | PSEUDOSCALAR MESONS | PAIR PRODUCTION | MATTER | MESONS | PHYSICS OF ELEMENTARY PARTICLES AND FIELDS | PARTICLE PRODUCTION | ANNIHILATION | PIONS MINUS | INTERACTIONS | ELEMENTARY PARTICLES | PIONS | GEV RANGE 01-10 | MUONS PLUS | GEV RANGE | PARTICLE INTERACTIONS | PIONS PLUS | POSITRONS | HADRONS
Journal Article
4.
Full Text
Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events
The New England journal of medicine, ISSN 0028-4793, 04/2006, Volume 354, Issue 16, pp. 1706 - 1717
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | General aspects | Medical sciences | Atherosclerosis (general aspects, experimental research) | Blood and lymphatic vessels | Myocardial Infarction - epidemiology | Prospective Studies | Ticlopidine - therapeutic use | Cardiovascular Diseases - drug therapy | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Aspirin - adverse effects | Ticlopidine - adverse effects | Aged, 80 and over | Cardiovascular Diseases - mortality | Adult | Female | Stroke - epidemiology | Aspirin - therapeutic use | Thrombosis - prevention & control | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Data Interpretation, Statistical | Stroke - prevention & control | Double-Blind Method | Risk Factors | Proportional Hazards Models | Ticlopidine - analogs & derivatives | Aged | Myocardial Infarction - prevention & control | Hemorrhage - chemically induced | Aspirin | Dosage and administration | Atheroembolism | Drug therapy | Comparative analysis | Clinical trials | Cardiovascular disease | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Physical review letters, ISSN 0031-9007, 2016, Volume 116, Issue 24, pp. 1 - 19
Journal Article
Physical review letters, ISSN 0031-9007, 2017, Volume 119, Issue 14, pp. 1 - 16
Journal Article